Literature DB >> 6675190

The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis.

P Kryger, P Schlichting, O Dietrichson, E Juhl.   

Abstract

Microfilms were prepared from the case histories of 357 consecutive patients submitted to liver biopsy for the first time so that all information after the time of the liver biopsy was erased. The microfilms were assessed by four clinicians, and the pre-biopsy diagnostic proposals were graded according to the degree of certainty and were compared with the results of the liver biopsies. Out of 357 patients, 200 had a history of alcoholism, of whom 172 had alcohol-induced changes in the liver biopsies: 80 cases of alcoholic cirrhosis, 84 cases of steatosis, and 8 cases of alcoholic hepatitis without cirrhosis. In 65 of the 80 patients with biopsy-verified alcoholic cirrhosis the clinical pre-biopsy diagnosis was in agreement with the histological findings. In 51 cases in which the clinical diagnosis of alcoholic cirrhosis was given as moderately certain or very certain, 4 clinically incorrect diagnoses occurred. No incorrect diagnoses occurred in the 35 cases in which the clinicians claimed the greatest diagnostic accuracy. In the 84 patients with steatosis in the liver biopsies the clinicians felt uncertain or moderately certain about all but 2 patients, and 14 incorrect diagnoses occurred. In none of the 8 patients with histological alcoholic hepatitis without cirrhosis was a correct clinical diagnosis made. The clinical pre-biopsy diagnosis of acute hepatitis was in agreement with the results of the liver biopsies in 52 out of 57 patients. In 51 cases in which the clinical diagnosis of acute hepatitis was given as moderately certain or very certain, 1 clinically incorrect diagnosis occurred.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1983        PMID: 6675190     DOI: 10.3109/00365528309181659

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis.

Authors:  Puneet Puri; Suthat Liangpunsakul; Jeffrey E Christensen; Vijay H Shah; Patrick S Kamath; Gregory J Gores; Susan Walker; Megan Comerford; Barry Katz; Andrew Borst; Qigui Yu; Divya P Kumar; Faridoddin Mirshahi; Svetlana Radaeva; Naga P Chalasani; David W Crabb; Arun J Sanyal
Journal:  Hepatology       Date:  2018-02-22       Impact factor: 17.425

Review 2.  Alcoholic Hepatitis: A Review.

Authors:  Nooshin Hosseini; Julia Shor; Gyongyi Szabo
Journal:  Alcohol Alcohol       Date:  2019-07-01       Impact factor: 2.826

3.  Decompensated cirrhosis-related admissions in a large urban hospital in Uganda: prevalence, clinical and laboratory features and implications for planning patient management.

Authors:  B S Apica; P Ocama; E Seremba; K C Opio; M M Kagimu
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

4.  Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.

Authors:  V Papastergiou; E A Tsochatzis; G Pieri; E Thalassinos; A Dhar; S Bruno; S Karatapanis; T V Luong; J O'Beirne; D Patch; D Thorburn; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2014-04       Impact factor: 8.171

Review 5.  Trends in the management and burden of alcoholic liver disease.

Authors:  Philippe Mathurin; Ramon Bataller
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

6.  Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.

Authors:  Hee Yeon Kim; Chang Wook Kim; Tae Yeob Kim; Do Seon Song; Dong Hyun Sinn; Eileen L Yoon; Young Kul Jung; Ki Tae Suk; Sang Soo Lee; Chang Hyeong Lee; Tae Hun Kim; Jeong Han Kim; Hyung Joon Yim; Sung Eun Kim; Soon Koo Baik; Byung Seok Lee; Jae Young Jang; Young Seok Kim; Sang Gyune Kim; Jin Mo Yang; Joo Hyun Sohn; Heon Ju Lee; Seung Ha Park; Eun Hee Choi; Dong Joon Kim
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.